G1 Therapeutics, Inc. GTHX
7.16 0.00 0.00%
As of Sep 17, 3:56 PM ET
52-week range unavailable
- Open
- 7.15
- Prev close
- 7.16
- Mkt cap
- 377.22M
- Vol
- 1.10M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 7.14
- High
- 7.16
- Forward P/E
- 0.00
- Beta
- 1.68
- Short ratio
- 1.01
- Inst. own
- 54.62%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 6, 2024
- 50-d avg
- 5.84
- 200-d avg
- 4.10
- 1y target
- 7.15
MAX chart
Chart tools
Chart is warming up
The all-time price history for GTHX has not been loaded yet. Try again in a moment.
Altman Z-Score
-8.10 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -3.3×
P/S 1.9×
P/B 4.5×
P/FCF -4.1×
EV/EBITDA -5.3×
EV/Sales 2.2×
FCF Yield -24.3%
Gross Margin 91.3%
Operating Margin -47.9%
Net Margin -58.1%
ROE -135.6%
ROIC -43.0%
ROA -39.5%
Revenue 60.8%
Operating Income 71.0%
EPS (diluted) 72.5%
Free Cash Flow 70.3%
Current Ratio 3.9×
Quick Ratio 3.4×
Debt / Equity 1.6×
Net Debt / EBITDA -0.7×
Interest Coverage -3.9×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2023-12-31